A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Clinical trial NCT00479765 · TERMINATED

Trial details

NCT number: NCT00479765
Sponsor: Boston Scientific Corporation
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Brain Neoplasms

Start date: 2007-03-01
Primary completion: 2009-10-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.